Cargando…

Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing

BACKGROUND: Lung adenocarcinoma (LA) is a most common form of non-small cell lung cancer (NSCLC). To date, there are still no effective early diagnosis methods for patients to be cured in time. Noncoding RNA plays an important role in oncogenesis and tumor development. The expression profile of circ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Yinyu, Xie, Fuyi, Huang, YunFei, Yang, Dongdong, Xu, Guodong, Wang, Chunnian, Wu, Qiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824818/
https://www.ncbi.nlm.nih.gov/pubmed/31626137
http://dx.doi.org/10.1097/MD.0000000000017601
_version_ 1783464807066763264
author Mu, Yinyu
Xie, Fuyi
Huang, YunFei
Yang, Dongdong
Xu, Guodong
Wang, Chunnian
Wu, Qiaoping
author_facet Mu, Yinyu
Xie, Fuyi
Huang, YunFei
Yang, Dongdong
Xu, Guodong
Wang, Chunnian
Wu, Qiaoping
author_sort Mu, Yinyu
collection PubMed
description BACKGROUND: Lung adenocarcinoma (LA) is a most common form of non-small cell lung cancer (NSCLC). To date, there are still no effective early diagnosis methods for patients to be cured in time. Noncoding RNA plays an important role in oncogenesis and tumor development. The expression profile of circular RNA (circRNA) in peripheral whole blood (PWB) of LA has not been systematically investigated. In this study, we identified the differentially expressed (DE) circRNAs in PWB of LA by high-throughput sequencing. METHODS: Five paired LA and normal participants PWB samples were chosen to investigate the expression profile of circRNAs by high-throughput sequencing. Twenty LA and 10 normal controls PWB samples were subjected to reverse-transcription polymerase chain reaction (RT-PCR) for validation of circRNAs expression profile. Gene Ontology (GO) functional analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and circRNA-miRNA network analysis was also performed to predict the function of circRNAs in PWB. RESULTS: A total of 10566 circRNAs were identified and annotated, most of the circRNAs were exonic (78.14%). Statistical analysis revealed 4390 DE circRNAs, in which were 3009 upregulated circRNAs and1381downregulated circRNAs in LA. RT-PCR results showed that circRNA expression in LA was higher than that in controls. GO functional analysis, KEGG pathway analysis, and circRNA-miRNA network analysis all showed that circRNAs correlated with tumor development and progression to a certain degree. The current study is the first to systematically characterize and annotate circRNA expression in PWB of LA. Some host genes of the DE circRNAs were involved in tumor signaling pathway and had complicated correlations with tumor related miRNAs, indicating that circRNAs might involve in development and progression of LA. CONCLUSIONS: Our study revealed that circRNAs were abnormally expressed in PWB of LA, which might offer potential targets for the early diagnosis of the disease and new genetic insights into LA.
format Online
Article
Text
id pubmed-6824818
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68248182019-11-19 Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing Mu, Yinyu Xie, Fuyi Huang, YunFei Yang, Dongdong Xu, Guodong Wang, Chunnian Wu, Qiaoping Medicine (Baltimore) 5700 BACKGROUND: Lung adenocarcinoma (LA) is a most common form of non-small cell lung cancer (NSCLC). To date, there are still no effective early diagnosis methods for patients to be cured in time. Noncoding RNA plays an important role in oncogenesis and tumor development. The expression profile of circular RNA (circRNA) in peripheral whole blood (PWB) of LA has not been systematically investigated. In this study, we identified the differentially expressed (DE) circRNAs in PWB of LA by high-throughput sequencing. METHODS: Five paired LA and normal participants PWB samples were chosen to investigate the expression profile of circRNAs by high-throughput sequencing. Twenty LA and 10 normal controls PWB samples were subjected to reverse-transcription polymerase chain reaction (RT-PCR) for validation of circRNAs expression profile. Gene Ontology (GO) functional analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and circRNA-miRNA network analysis was also performed to predict the function of circRNAs in PWB. RESULTS: A total of 10566 circRNAs were identified and annotated, most of the circRNAs were exonic (78.14%). Statistical analysis revealed 4390 DE circRNAs, in which were 3009 upregulated circRNAs and1381downregulated circRNAs in LA. RT-PCR results showed that circRNA expression in LA was higher than that in controls. GO functional analysis, KEGG pathway analysis, and circRNA-miRNA network analysis all showed that circRNAs correlated with tumor development and progression to a certain degree. The current study is the first to systematically characterize and annotate circRNA expression in PWB of LA. Some host genes of the DE circRNAs were involved in tumor signaling pathway and had complicated correlations with tumor related miRNAs, indicating that circRNAs might involve in development and progression of LA. CONCLUSIONS: Our study revealed that circRNAs were abnormally expressed in PWB of LA, which might offer potential targets for the early diagnosis of the disease and new genetic insights into LA. Wolters Kluwer Health 2019-10-18 /pmc/articles/PMC6824818/ /pubmed/31626137 http://dx.doi.org/10.1097/MD.0000000000017601 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 5700
Mu, Yinyu
Xie, Fuyi
Huang, YunFei
Yang, Dongdong
Xu, Guodong
Wang, Chunnian
Wu, Qiaoping
Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
title Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
title_full Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
title_fullStr Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
title_full_unstemmed Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
title_short Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
title_sort circular rna expression profile in peripheral whole blood of lung adenocarcinoma by high: throughput sequencing
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824818/
https://www.ncbi.nlm.nih.gov/pubmed/31626137
http://dx.doi.org/10.1097/MD.0000000000017601
work_keys_str_mv AT muyinyu circularrnaexpressionprofileinperipheralwholebloodoflungadenocarcinomabyhighthroughputsequencing
AT xiefuyi circularrnaexpressionprofileinperipheralwholebloodoflungadenocarcinomabyhighthroughputsequencing
AT huangyunfei circularrnaexpressionprofileinperipheralwholebloodoflungadenocarcinomabyhighthroughputsequencing
AT yangdongdong circularrnaexpressionprofileinperipheralwholebloodoflungadenocarcinomabyhighthroughputsequencing
AT xuguodong circularrnaexpressionprofileinperipheralwholebloodoflungadenocarcinomabyhighthroughputsequencing
AT wangchunnian circularrnaexpressionprofileinperipheralwholebloodoflungadenocarcinomabyhighthroughputsequencing
AT wuqiaoping circularrnaexpressionprofileinperipheralwholebloodoflungadenocarcinomabyhighthroughputsequencing